Relief Therapeutics Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTD) (“Relief”), and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (“NRx Pharmaceuticals”), today announced that they have entered into definitive settlement agreements to resolve their pending litigation.
Nov. 13, 2022Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Aug. 22, 2022Relief Therapeutics Holding SA And NRx Pharmaceuticals, Inc. Announce Tentative Settlement Of Pending Litigation
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. today announced that they have agreed to a tentative settlement of their pending litigation. The parties have agreed to work collaboratively to finalize the settlement within the next 30 days.